The incidence of cocaine-related sudden deaths has reached epidemic proportions in many metropolitan areas around the United States. Widespread cocaine abuse is associated with significant neuropsychiatric and from 1978 - 1985 has revealed a number of important findings regarding the temporal trends and risk factors surrounding cocaine-related sudden death. The epidemiological findings indicate that in Dade County only 6 to 11% of the cases had significant underlying coronary artery disease or ventricular hypertrophy, suggesting that these risk factors may account for only a subgroup of the cocaine-related deaths. In addition, polydrug abuse does not appear to be a significant risk factor in Dade County. High dose cocaine toxicity is associated with seizures. However, the percentage of cocaine-related deaths with seizures has declined during the epidemic. This pattern is consistent with toxicology findings which demonstrate that median plasma concentration of cocaine associated with sudden death also appear to be declining annually. In contrast, an increased incidence of preterminal excited delirium and sudden death has been reported which closely follows the epidemic curve for cocaine-related deaths in Dade County. These observations suggest that the causes of cocaine-related death in decedents with comparatively low concentrations of blood cocaine may be different from the high dose toxicity group. The precise pathophysiological mechanisms leading to cocaine-related sudden death are not well defined and, at present, all known mechanisms fail to explain why cocaine abuse may have divergent effects on the heart. Our hypothesis is that cocaine abuse results in abnormal neuronal activity in limbic and brainstem centers comprising the neural substrates which mediate central autonomic functions. Abnormal neurochemical transmission in these pathways may, in addition to the direct cardiotoxic effects of cocaine, lead to the pathogenesis of cocaine-related sudden death. The present proposal seeks funds for systematic post mortem studies of the chemo- and pathoarchitecture in brains from victims of cocaine-related death. Using rigorous inclusion criteria for cocaine exposure, the cases selected for neuroanatomical studies will be classified into the following subgroups : high dose toxicity (seizures); low dose toxicity without significant underlying cardiac pathology; and cocaine-related death in subjects exhibiting preterminal excited delirium. We propose to characterize post mortem neurochemical alteration in brains from victims of cocaine-related sudden death using in vitro autoradiography on whole-brain sections. The distribution and status of norepinephrine and dopamine terminals will be visualized in whole-brain sections by receptor subtypes and sigma receptors will be correlated with limbic and medullary pathoarchitecture and whenever possible with the pattern of use and drug and metabolite levels in plasma and brains. The proposed anatomical studies may disclose the toxic effects of an neural sites for the action of cocaine in the human brain. These studies may provide a basis for pharmacologically targeting multiple, interactive dysfunctions in the brain in order to halt cocaine abuse in chronic users.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA006227-02
Application #
3212816
Study Section
Special Emphasis Panel (SRCD (10))
Project Start
1990-04-01
Project End
1993-04-30
Budget Start
1991-04-01
Budget End
1992-04-30
Support Year
2
Fiscal Year
1991
Total Cost
Indirect Cost
Name
University of Miami School of Medicine
Department
Type
Schools of Medicine
DUNS #
City
Miami
State
FL
Country
United States
Zip Code
33146
Zhang, Mingfeng; Lykke-Andersen, Soren; Zhu, Bin et al. (2018) Characterising cis-regulatory variation in the transcriptome of histologically normal and tumour-derived pancreatic tissues. Gut 67:521-533
Agrawal, A; Chou, Y-L; Carey, C E et al. (2018) Genome-wide association study identifies a novel locus for cannabis dependence. Mol Psychiatry 23:1293-1302
Varma, V R; Varma, S; An, Y et al. (2017) Alpha-2 macroglobulin in Alzheimer's disease: a marker of neuronal injury through the RCAN1 pathway. Mol Psychiatry 22:13-23
Mohammadi, Pejman; Castel, Stephane E; Brown, Andrew A et al. (2017) Quantifying the regulatory effect size of cis-acting genetic variation using allelic fold change. Genome Res 27:1872-1884
Li, Xin; Kim, Yungil; Tsang, Emily K et al. (2017) The impact of rare variation on gene expression across tissues. Nature 550:239-243
Peckham-Gregory, Erin C; Chakraborty, Rikhia; Scheurer, Michael E et al. (2017) A genome-wide association study of LCH identifies a variant in SMAD6 associated with susceptibility. Blood 130:2229-2232
Saha, Ashis; Kim, Yungil; Gewirtz, Ariel D H et al. (2017) Co-expression networks reveal the tissue-specific regulation of transcription and splicing. Genome Res 27:1843-1858
Mercader, Josep M; Liao, Rachel G; Bell, Avery D et al. (2017) A Loss-of-Function Splice Acceptor Variant in IGF2 Is Protective for Type 2 Diabetes. Diabetes 66:2903-2914
Yang, Bo; Zhou, Wei; Jiao, Jiao et al. (2017) Protein-altering and regulatory genetic variants near GATA4 implicated in bicuspid aortic valve. Nat Commun 8:15481
Manning, Alisa (see original citation for additional authors) (2017) A Low-Frequency Inactivating AKT2 Variant Enriched in the Finnish Population Is Associated With Fasting Insulin Levels and Type 2 Diabetes Risk. Diabetes 66:2019-2032

Showing the most recent 10 out of 98 publications